{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:17:21Z","timestamp":1787584641687,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.therap.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T18:53:37Z","timestamp":1561056817000},"page":"225-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The drugs that mostly frequently induce gynecomastia: A national case\u00a0\u2013\u00a0noncase study"],"prefix":"10.1016","volume":"75","author":[{"given":"Benjamin","family":"Batteux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Moragny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2019.06.001_bib0425","first-page":"145","article-title":"Gynecomastia\u00a0\u2013\u00a0evaluation and current treatment options","volume":"7","author":"Johnson","year":"2011","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0430","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1743-6109.2008.01053.x","article-title":"The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management","volume":"6","author":"Wassersug","year":"2009","journal-title":"J Sex Med"},{"issue":"5","key":"10.1016\/j.therap.2019.06.001_bib0435","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/SAP.0b013e3181dba827","article-title":"Adolescent gynecomastia: not only an obesity issue","volume":"64","author":"Rosen","year":"2010","journal-title":"Ann Plast Surg"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0440","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.GME.0000055522.67459.89","article-title":"A physiologic role for testosterone in limiting estrogenic stimulation of the breast","volume":"10","author":"Dimitrakakis","year":"2003","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.therap.2019.06.001_bib0445","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMcp070677","article-title":"Gynecomastia","volume":"357","author":"Braunstein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2019.06.001_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-69869-9_1","article-title":"Sertoli cells and Leydig cells in man","volume":"88","author":"Schulze","year":"1984","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0455","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1210\/jcem-53-1-58","article-title":"Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma","volume":"53","author":"Dunn","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0460","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv-11-1-80","article-title":"The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances","volume":"11","author":"Rosner","year":"1990","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0465","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ecl.2007.03.013","article-title":"Gynecomastia","volume":"36","author":"Narula","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.therap.2019.06.001_bib0470","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1743-6109.2007.00569.x","article-title":"Effect of hyperprolactinemia in male patients consulting for sexual dysfunction","volume":"4","author":"Corona","year":"2007","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0475","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199307153290316","article-title":"Gynecomastia","volume":"329","author":"Williams","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.therap.2019.06.001_bib0480","first-page":"797","article-title":"The formation of acinar tissue in gynecomastia","volume":"43","author":"Schwartz","year":"1963","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0485","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1210\/jcem-66-1-230","article-title":"High serum progesterone in hyperthyroid men with graves\u2019 disease","volume":"66","author":"Nomura","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.therap.2019.06.001_bib0490","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00006534-200010000-00009","article-title":"Estrogen and progesterone receptors in gynecomastia","volume":"106","author":"Pensler","year":"2000","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0495","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1524-4741.2011.01080.x","article-title":"Overview of gynecomastia in the modern era and the leeds gynaecomastia investigation algorithm","volume":"17","author":"Rahmani","year":"2011","journal-title":"Breast J"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0500","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an endocrine society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.therap.2019.06.001_bib0505","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/phar.1138","article-title":"Drug-induced gynecomastia","volume":"32","author":"Bowman","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0510","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1517\/14740330802442382","article-title":"Drug-induced gynecomastia","volume":"7","author":"Eckman","year":"2008","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0515","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.therap.2016.02.029","article-title":"French pharmacovigilance: missions, organization and perspectives","volume":"71","author":"Vial","year":"2016","journal-title":"Therapie"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0520","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapie"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0525","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The Medical Dictionary for Regulatory Activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0530","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","article-title":"Case-non-case studies: principle, methods, bias and interpretation","volume":"74","author":"Faillie","year":"2019","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0535","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","article-title":"On estimating the relation between blood group and disease","volume":"19","author":"Woolf","year":"1955","journal-title":"Ann Hum Genet"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0540","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-48-2-338","article-title":"Gynecomastia as a physical finding in normal men","volume":"48","author":"Nuttall","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0545","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(84)90353-X","article-title":"Gynecomastia in a hospitalized male population","volume":"77","author":"Niewoehner","year":"1984","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.therap.2019.06.001_bib0550","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00228-015-1835-x","article-title":"Gynecomastia and drugs: a critical evaluation of the literature","volume":"71","author":"Nuttall","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.therap.2019.06.001_bib0555","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/00365540110026476","article-title":"Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy","volume":"33","author":"Piroth","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1016\/j.therap.2019.06.001_bib0560","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/343045","article-title":"Breast enlargement in 13 men who were seropositive for human immunodeficiency virus","volume":"35","author":"Evans","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0565","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1258\/0956462021924514","article-title":"True gynaecomastia, another manifestation of immune reconstitution disease?","volume":"13","author":"Qazi","year":"2002","journal-title":"Int J STD AIDS"},{"issue":"9184","key":"10.1016\/j.therap.2019.06.001_bib0570","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0575","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jcem-45-2-255","article-title":"Gynecomastia and semen abnormalities induced by spironolactone in normal men","volume":"45","author":"Caminos-Torres","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0580","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cpt1978244465","article-title":"Gynecomastia induced in normal males by spironolactone","volume":"24","author":"Huffman","year":"1978","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.therap.2019.06.001_bib0585","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0590","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","article-title":"Interaction of spironolactone with oestradiol receptors in cytosol","volume":"84","author":"Levy","year":"1980","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0595","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-87-4-398","article-title":"Pathophysiology of spironolactone-induced gynecomastia","volume":"87","author":"Rose","year":"1977","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0600","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jcem-43-6-1386","article-title":"Spironolactone stimulation of gonadotropin secretion in boys with delayed adolescence","volume":"43","author":"Santen","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"issue":"6927","key":"10.1016\/j.therap.2019.06.001_bib0605","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/bmj.308.6927.503","article-title":"Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs","volume":"308","author":"Garc\u00eda Rodr\u00edguez","year":"1994","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0610","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2125.2000.00262.x","article-title":"The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies","volume":"50","author":"Martin","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0615","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/00002018-200730060-00006","article-title":"Gynaecomastia associated with proton pump inhibitors","volume":"30","author":"Carvajal","year":"2007","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0620","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1743-6109.2009.01698.x","article-title":"The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction","volume":"7","author":"Corona","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.therap.2019.06.001_bib0625","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.reprotox.2013.12.010","article-title":"Statin drugs markedly inhibit testosterone production by rat Leydig cells in vitro: implications for men","volume":"45","author":"Klinefelter","year":"2014","journal-title":"Reprod Toxicol"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0630","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1592\/phco.26.6.748","article-title":"Atypical antipsychotics and pituitary tumors: a pharmacovigilance study","volume":"26","author":"Szarfman","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0635","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2006.07.006","article-title":"Amisulpride-induced hyperprolactinemia is reversible following discontinuation","volume":"31","author":"Paparrigopoulos","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.therap.2019.06.001_bib0640","first-page":"27","article-title":"Schizophrenia outpatient health outcomes study: twelve-month findings","volume":"3","author":"Novick","year":"2012","journal-title":"Pragmat Obs Res"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0645","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1054\/brst.2001.0308","article-title":"Amlodipine gynaecomastia","volume":"10","author":"Cornes","year":"2001","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0650","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-60-1-144","article-title":"Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone- stimulated anterior pituitary hormone secretion in man","volume":"60","author":"Veldhuis","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.therap.2019.06.001_bib0655","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1464-410X.2009.08915.x","article-title":"Effect of the dual 5\u03b1-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia","volume":"105","author":"Hong","year":"2010","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0660","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0090-4295(97)00457-3","article-title":"Tamoxifen for flutamide\/finasteride-induced gynecomastia","volume":"50","author":"Staiman","year":"1997","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0665","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000441-199506000-00005","article-title":"Finasteride-induced gynecomastia in a 62-year-old man","volume":"309","author":"Volpi","year":"1995","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0670","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1464-410X.1996.00091.x","article-title":"The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients","volume":"78","author":"Wilton","year":"1996","journal-title":"Br J Urol"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0675","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0039-128X(98)00005-1","article-title":"Effects of the 5\u03b1-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study","volume":"63","author":"Uygur","year":"1998","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0680","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00002018-200225060-00010","article-title":"Use of measures of disproportionality in pharmacovigilance: three Dutch examples","volume":"25","author":"Egberts","year":"2002","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0685","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0690","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.therap.2017.06.002","article-title":"Hyperprolactinemia with galactorrhea induced by lansoprazole: a case report","volume":"72","author":"Duwicquet","year":"2017","journal-title":"Therapie"},{"issue":"7\u20138","key":"10.1016\/j.therap.2019.06.001_bib0695","first-page":"955","article-title":"Euprolactinemic galactorrhea secondary to domperidone treatment","volume":"28","author":"Demir","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.therap.2019.06.001_bib0700","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM198612113152419","article-title":"Amiodarone-induced gynecomastia","volume":"315","author":"Antonelli","year":"1986","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0705","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2515\/therapie\/2012001","article-title":"Mechanisms of digoxin-induced gynecomastia: a case report and literature review","volume":"67","author":"Affes","year":"2012","journal-title":"Therapie"},{"issue":"12","key":"10.1016\/j.therap.2019.06.001_bib0710","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.4088\/JCP.v66n1219f","article-title":"Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child","volume":"66","author":"Mendhekar","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0715","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archinte.1988.00380020123017","article-title":"Gynecomastia associated with calcium channel blocker therapy","volume":"148","author":"Tanner","year":"1988","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0720","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1875-9114.1993.tb02688.x","article-title":"Drug-induced gynecomastia","volume":"13","author":"Thompson","year":"1993","journal-title":"Pharmacotherapy"},{"issue":"6723","key":"10.1016\/j.therap.2019.06.001_bib0725","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.300.6723.541","article-title":"Gynaecomastia induced by angiotensin converting enzyme inhibitor","volume":"300","author":"Nakamura","year":"1990","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0730","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1345\/aph.1H475","article-title":"Gynecomastia associated with fenofibrate","volume":"41","author":"Gardette","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0735","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2340\/00015555-1013","article-title":"Isotretinoin influences pituitary hormone levels in acne patients","volume":"91","author":"Karadag","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.therap.2019.06.001_bib0740","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/19440041003660869","article-title":"Gynaecomastia linked to the intake of a herbal supplement fortified with diethylstilbestrol","volume":"27","author":"Toorians","year":"2010","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"9","key":"10.1016\/j.therap.2019.06.001_bib0745","first-page":"687","article-title":"Endocrine complications of androgen-deprivation therapy in men with prostate cancer","volume":"4","author":"Harle","year":"2006","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0750","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00432-006-0133-5","article-title":"Antiandrogen treatments in locally advanced prostate cancer: are they all the same?","volume":"132","author":"Gillatt","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0755","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont","year":"1982","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0760","first-page":"51","article-title":"Isoniazid induced gynaecomastia: a case report","volume":"56","author":"Garg","year":"2009","journal-title":"Indian J Tuberc"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0765","first-page":"277","article-title":"Isoniazid associated, painful, bilateral gynaecomastia","volume":"45","author":"Khanna","year":"2003","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"4","key":"10.1016\/j.therap.2019.06.001_bib0770","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/135965350400900416","article-title":"Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment","volume":"9","author":"Mira","year":"2004","journal-title":"Antivir Ther (Lond)"},{"issue":"6","key":"10.1016\/j.therap.2019.06.001_bib0775","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/s10165-007-0619-2","article-title":"Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis","volume":"17","author":"Abe","year":"2007","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.therap.2019.06.001_bib0780","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.bmt.1703302","article-title":"Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy","volume":"28","author":"Harris","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.therap.2019.06.001_bib0785","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/leu.2008.106","article-title":"Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia","volume":"22","author":"Caocci","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.therap.2019.06.001_bib0790","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1078155211424629","article-title":"Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: a literature review","volume":"18","author":"Tanriverdi","year":"2012","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"10.1016\/j.therap.2019.06.001_bib0795","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00044011-200929070-00007","article-title":"Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma","volume":"29","author":"Ballardini","year":"2009","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.therap.2019.06.001_bib0800","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/clpt.1984.186","article-title":"Endocrine and clinical effects of leuprolide in prostatic cancer","volume":"36","author":"Vance","year":"1984","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.therap.2019.06.001_bib0805","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11934-016-0634-y","article-title":"Opioid-Induced Androgen Deficiency (OPIAD): diagnosis, management, and literature review","volume":"17","author":"O\u2019Rourke","year":"2016","journal-title":"Curr Urol Rep"},{"issue":"9","key":"10.1016\/j.therap.2019.06.001_bib0810","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1528-1167.2006.00713.x","article-title":"Two cases of painful gynecomastia and lower extremity pain in association with pregabalin therapy","volume":"47","author":"M\u00e1laga","year":"2006","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0815","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1345\/aph.1E294","article-title":"Diazepam-associated gynecomastia","volume":"39","author":"Jelenkovic","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.therap.2019.06.001_bib0820","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4088\/JCP.v65n0806","article-title":"\u201cDopamine-dependent\u201d side effects of selective serotonin reuptake inhibitors: a clinical review","volume":"65","author":"Damsa","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0825","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4158\/EP.2.1.4","article-title":"Hypogonadism and methadone: hypothalamic hypogonadism after long-term use of high-dose methadone","volume":"2","author":"de la Rosa","year":"1996","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.therap.2019.06.001_bib0830","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4158\/EP.9.5.370","article-title":"Epidemic of gynecomastia among haitian refugees: exposure to an environmental antiandrogen","volume":"9","author":"Brody","year":"2003","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0835","first-page":"141","article-title":"Gynecomastia associated with theophylline","volume":"18","author":"Dardick","year":"1984","journal-title":"J Fam Pract"},{"issue":"1","key":"10.1016\/j.therap.2019.06.001_bib0840","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2515\/therapie:2004031","article-title":"Two cases of gynaecomastia with cetirizine, a second-generation antihistamine","volume":"59","author":"Louis","year":"2004","journal-title":"Therapie"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:53:48Z","timestamp":1758567228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595719300988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0040595719300988"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2019.06.001","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The drugs that mostly frequently induce gynecomastia: A national case\u00a0\u2013\u00a0noncase study","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}